Loading...

Miceli, M Carrie

Title(s)Professor, Mimg
Phone3102066483
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Muscle Cell Biology, Pathophysiology, and Therapeutics
    NIH/NIAMS T32AR065972May 1, 2016 - Apr 30, 2021
    Role: Co-Principal Investigator
    Identification of Enhancers of Therapeutic Exon Skipping for DMD
    NIH/NIAMS RC1AR058333Sep 25, 2009 - Aug 31, 2011
    Role: Principal Investigator
    Galectin-1 regulation of T cell activation and tolerance
    NIH/NIAID R01AI056155Jun 15, 2003 - Nov 30, 2008
    Role: Principal Investigator
    Coreceptor Modification of TCR Tyrosine Kinase Signals
    NIH/NIAID R01AI067253Dec 8, 1994 - Mar 31, 2011
    Role: Principal Investigator
    CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS
    NIH/NCI R01CA065979Dec 8, 1994 - Jun 30, 2005
    Role: Principal Investigator
    CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS
    NIH/NCI R29CA065979Dec 8, 1994 - Jun 30, 2000
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Miceli MC, Nelson SF. The case for eteplirsen: Paving the way for precision medicine. Mol Genet Metab. 2016 06; 118(2):70-1. PMID: 27102846.
      View in: PubMed
    2. Miceli MC, Moran M, Chung CD, Patel VP, Low T, Zinnanti W. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin Immunol. 2001 Apr; 13(2):115-28. PMID: 11308295.
      View in: PubMed